SCHEMBL20161852

SCHEMBL20161852

C=CC(=O)N1CCN(C(=O)c2cc(Sc3cnc(NC(=O)C4CC4)s3)c(C)cc2OC)C[C@H]1N

nearest known ligand 0.86

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BTK Q06187 18/20 0.86
JAK3 P52333 18/20 0.86
TXK P42681 15/20 0.86
ITK Q08881 4/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24467192 0.93 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161719 0.93 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161721 0.93 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161701 0.91 BTK (1.00) BTKJAK3TXKITK
SCHEMBL20161227 0.91 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161702 0.91 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161489 0.90 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL24467241 0.90 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161484 0.90 JAK3 (1.00) BTKJAK3TXKITK
SCHEMBL20161523 0.89 JAK3 (1.00) BTKJAK3TXKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed